ACHC LEGAL DEADLINE: Acadia Healthcare Class Action Deadline is Approaching – Contact BFA Law if You Suffered Losses (Nasdaq:ACHC)

Core Viewpoint - A lawsuit has been filed against Acadia Healthcare Company, Inc. and certain senior executives, alleging misrepresentation of financial results related to insurance fraud and improper patient detainment practices [1][3]. Legal Proceedings - Investors have until December 16, 2024, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Dyar v. Acadia Healthcare Company, Inc. [2]. Allegations - The lawsuit claims that Acadia misrepresented its financial performance, attributing it to fraudulent practices and holding patients against their will when not medically necessary [3]. Stock Price Impact - Following a New York Times article on September 1, 2024, which detailed Acadia's practices, the stock price fell by $3.72 (4.5%) to $78.21 on September 3, 2024 [4]. - On September 27, 2024, Acadia disclosed receiving requests for information from the U.S. Attorney's Office and a grand jury subpoena, leading to a 16% decline in stock price from $75.66 to $63.28 [5]. - An October 18, 2024, article reported an investigation by the Veterans Affairs Department into potential insurance fraud, causing a 12% drop in stock price from $59.32 to $52.03 [6]. Company Background - Acadia Healthcare is one of the largest for-profit chains of psychiatric hospitals in the United States [3].